INTEGRATED BIOPHARMA INC Interest Expense Nonoperating
INTEGRATED BIOPHARMA INC (INBP) reported Interest Expense Nonoperating of -$39.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-05-08
- INTEGRATED BIOPHARMA INC interest expense nonoperating for the quarter ending 2026-03-31 was -$39.00K.
- INTEGRATED BIOPHARMA INC interest expense nonoperating for the quarter ending 2025-12-31 was -$40.00K.
- INTEGRATED BIOPHARMA INC interest expense nonoperating for the quarter ending 2025-09-30 was -$33.00K.
- INTEGRATED BIOPHARMA INC interest expense nonoperating for the quarter ending 2025-06-30 was -$9.00K.
- INTEGRATED BIOPHARMA INC interest expense nonoperating for fiscal 2025 was -$39.00K.
- INTEGRATED BIOPHARMA INC interest expense nonoperating for fiscal 2024 was -$18.00K, a 228.57% decline from fiscal 2023.
- INTEGRATED BIOPHARMA INC interest expense nonoperating for fiscal 2023 was $14.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$39.00K 10-Q · filed 2026-05-08 | -$79.00K derived: sum of 2 quarters · filed 2026-05-08 | -$112.00K 10-Q · filed 2026-05-08 | -$121.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-12-31 | -$40.00K 10-Q · filed 2026-02-11 | -$73.00K 10-Q · filed 2026-02-11 | -$82.00K derived: sum of 3 quarters · filed 2026-02-11 | -$87.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-09-30 | -$33.00K 10-Q · filed 2025-11-10 | -$42.00K derived: sum of 2 quarters · filed 2025-11-10 | -$47.00K derived: sum of 3 quarters · filed 2026-05-08 | -$58.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-06-30 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | -$14.00K derived: sum of 2 quarters · filed 2026-05-08 | -$25.00K derived: sum of 3 quarters · filed 2026-05-08 | -$39.00K 10-K · filed 2025-09-23 |
| 2025-03-31 | -$5.00K 10-Q · filed 2026-05-08 | -$16.00K derived: sum of 2 quarters · filed 2026-05-08 | -$30.00K 10-Q · filed 2026-05-08 | -$42.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$11.00K 10-Q · filed 2026-02-11 | -$25.00K 10-Q · filed 2026-02-11 | -$37.00K derived: sum of 3 quarters · filed 2026-02-11 | -$33.00K derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | -$14.00K 10-Q · filed 2025-11-10 | -$26.00K derived: sum of 2 quarters · filed 2025-11-10 | -$22.00K derived: sum of 3 quarters · filed 2025-11-10 | -$24.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | -$8.00K derived: sum of 2 quarters · filed 2025-09-23 | -$10.00K derived: sum of 3 quarters · filed 2025-09-23 | -$18.00K 10-K · filed 2025-09-23 |
| 2024-03-31 | $4.00K 10-Q · filed 2025-05-14 | $2.00K derived: sum of 2 quarters · filed 2025-05-14 | -$6.00K 10-Q · filed 2025-05-14 | |
| 2023-12-31 | -$2.00K 10-Q · filed 2025-02-13 | -$10.00K 10-Q · filed 2025-02-13 | ||
| 2023-09-30 | -$8.00K 10-Q · filed 2024-11-13 | |||
| 2023-06-30 | $14.00K 10-K · filed 2024-09-20 |